Simplex Trading, LLC Vanda Pharmaceuticals Inc. Transaction History

Simplex Trading, LLC

  • $2.81 Billion
  • Q3 2024

A detailed history of Simplex Trading, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 10,194 shares of VNDA stock, worth $44,955. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,194
Previous 23,920 57.38%
Holding current value
$44,955
Previous $135,000 65.19%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
SELL
$4.61 - $6.34 $63,276 - $87,022
-13,726 Reduced 57.38%
10,194 $47,000
Q2 2024

Jul 25, 2024
SELL
$3.91 - $6.5 $36,859 - $61,275
-9,427 Reduced 28.27%
23,920 $135,000
Q1 2024

Apr 25, 2024
BUY
$3.47 - $4.61 $90,018 - $119,592
25,942 Added 350.33%
33,347 $137,000
Q4 2023

Feb 02, 2024
BUY
$3.38 - $4.58 $20,699 - $28,047
6,124 Added 478.06%
7,405 $31,000
Q3 2023

Nov 01, 2023
BUY
$4.28 - $6.57 $5,482 - $8,416
1,281 New
1,281 $5,000
Q1 2023

Apr 27, 2023
BUY
$6.18 - $7.99 $10,543 - $13,630
1,706 New
1,706 $11,000
Q2 2021

Aug 12, 2021
SELL
$15.71 - $21.51 $8,373 - $11,464
-533 Closed
0 $0
Q1 2021

Apr 26, 2021
BUY
$13.42 - $20.28 $7,152 - $10,809
533 New
533 $8,000
Q4 2020

Feb 02, 2021
SELL
$9.77 - $13.81 $35,005 - $49,481
-3,583 Closed
0 $0
Q3 2020

Oct 14, 2020
SELL
$9.32 - $12.02 $1,314 - $1,694
-141 Reduced 3.79%
3,583 $34,000
Q2 2020

Jul 13, 2020
SELL
$9.66 - $12.02 $137,993 - $171,705
-14,285 Reduced 79.32%
3,724 $42,000
Q1 2020

Apr 29, 2020
BUY
$7.5 - $16.8 $109,027 - $244,221
14,537 Added 418.69%
18,009 $186,000
Q4 2019

Feb 05, 2020
BUY
$12.38 - $17.47 $42,983 - $60,655
3,472 New
3,472 $56,000
Q1 2019

Apr 18, 2019
SELL
$17.59 - $31.05 $179,541 - $316,927
-10,207 Closed
0 $0
Q4 2018

Jan 16, 2019
SELL
$18.97 - $31.47 $1.09 Million - $1.81 Million
-57,379 Reduced 84.9%
10,207 $266,000
Q3 2018

Oct 23, 2018
BUY
$18.25 - $23.0 $1.19 Million - $1.5 Million
65,389 Added 2976.29%
67,586 $1.55 Million
Q2 2018

Jul 30, 2018
SELL
$13.95 - $19.15 $51,349 - $70,491
-3,681 Reduced 62.62%
2,197 $41,000
Q1 2018

Apr 26, 2018
SELL
$14.05 - $20.2 $17,141 - $24,644
-1,220 Reduced 17.19%
5,878 $99,000
Q4 2017

Jan 10, 2018
SELL
$12.85 - $18.1 $44,358 - $62,481
-3,452 Reduced 32.72%
7,098 $107,000
Q3 2017

Oct 25, 2017
BUY
$15.4 - $18.85 $162,470 - $198,867
10,550
10,550 $188,000

Others Institutions Holding VNDA

# of Institutions
157
Shares Held
44.9M
Call Options Held
165K
Put Options Held
33.6K
View Full List

About Vanda Pharmaceuticals Inc.

VNDA Quotes by TradingView
  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $249M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email